Holen Sie sich die Stockscreener-App
7.32
4.69%
-0.36
Handel nachbörslich:
7.23
-0.09
-1.23%
Schlusskurs vom Vortag:
$7.68
Offen:
$7.71
24-Stunden-Volumen:
65,092
Relative Volume:
1.96
Marktkapitalisierung:
$23.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.80M
KGV:
-6.2564
EPS:
-1.17
Netto-Cashflow:
$-59.06M
1W Leistung:
+1.67%
1M Leistung:
-7.92%
6M Leistung:
+1,753%
1J Leistung:
+1,063%
1-Tages-Spanne:
$7.23
$7.91
1-Wochen-Bereich:
$7.00
$7.91
52-Wochen-Spanne:
$0.257
$9.00
Passage Bio Inc Stock (PASG) Company Profile
Firmenname
Passage Bio Inc
Sektor
Branche
Telefon
(267) 866-0312
Adresse
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Vergleichen Sie PASG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.32 | 24.41M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-09-03 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-03-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Herabstufung | Goldman | Buy → Neutral |
| 2021-07-01 | Eingeleitet | Raymond James | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-03-04 | Hochstufung | Goldman | Neutral → Buy |
| 2021-02-04 | Eingeleitet | Guggenheim | Buy |
| 2021-01-25 | Eingeleitet | Wedbush | Outperform |
| 2021-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-08-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-03-24 | Eingeleitet | Cowen | Outperform |
| 2020-03-24 | Eingeleitet | Goldman | Buy |
| 2020-03-24 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Passage Bio Inc Aktie (PASG) Neueste Nachrichten
Why Passage Bio Inc. stock remains a top recommendationJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com
Market reaction to Passage Bio Inc.’s recent newsTrade Risk Assessment & Reliable Price Action Trade Plans - newser.com
How to recover losses in Passage Bio Inc. stockJuly 2025 Retail & Safe Swing Trade Setups - newser.com
Will Passage Bio Inc. price bounce be sustainableGDP Growth & Fast Gain Stock Trading Tips - newser.com
What momentum shifts mean for Passage Bio Inc.2025 Volatility Report & Verified Entry Point Signals - newser.com
Can Passage Bio Inc. stock attract ESG capital inflows2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Why Passage Bio Inc. is moving todayJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
Using economic indicators to assess Passage Bio Inc. potentialWeekly Profit Report & Free Daily Entry Point Trade Alerts - newser.com
Combining machine learning predictions for Passage Bio Inc.Portfolio Risk Summary & Verified Entry Point Signals - newser.com
Passage Bio Inc. stock trendline breakdown2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Is Passage Bio Inc. stock bottoming outJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
Applying chart zones and confluence areas to Passage Bio Inc.2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com
Why Passage Bio Inc. stock could rally in 2025Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - newser.com
Multi asset correlation models including Passage Bio Inc.2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
How Passage Bio Inc. stock reacts to global recession fearsJuly 2025 Big Picture & Low Drawdown Trading Techniques - newser.com
Smart tools for monitoring Passage Bio Inc.’s price action2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
Ocugen to Announce Third-Quarter 2025 Results and Business Update on November 5 - MyChesCo
Predicting Passage Bio Inc. trend using moving averagesJuly 2025 Analyst Calls & Short-Term High Return Ideas - newser.com
Can you recover from losses in Passage Bio Inc.2025 Market Overview & Precise Buy Zone Tips - newser.com
Ranking Passage Bio Inc. among high performing stocks via toolsWeekly Profit Report & Verified Swing Trading Watchlist - newser.com
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):